189 related articles for article (PubMed ID: 30653571)
1. The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies.
Pilch Z; Tonecka K; Skorzynski M; Sas Z; Braniewska A; Kryczka T; Boon L; Golab J; Meyaard L; Rygiel TP
PLoS One; 2019; 14(1):e0210796. PubMed ID: 30653571
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Activity of TLR7 Is Potentiated by CD200R Antibody Leading to Changes in the Tumor Microenvironment.
Pilch Z; Tonecka K; Braniewska A; Sas Z; Skorzynski M; Boon L; Golab J; Meyaard L; Rygiel TP
Cancer Immunol Res; 2018 Aug; 6(8):930-940. PubMed ID: 30021725
[TBL] [Abstract][Full Text] [Related]
3. A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.
Liu JQ; Talebian F; Wu L; Liu Z; Li MS; Wu L; Zhu J; Markowitz J; Carson WE; Basu S; Bai XF
J Immunol; 2016 Aug; 197(4):1489-97. PubMed ID: 27385779
[TBL] [Abstract][Full Text] [Related]
4. CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.
Rygiel TP; Karnam G; Goverse G; van der Marel AP; Greuter MJ; van Schaarenburg RA; Visser WF; Brenkman AB; Molenaar R; Hoek RM; Mebius RE; Meyaard L
Oncogene; 2012 Jun; 31(24):2979-88. PubMed ID: 22020332
[TBL] [Abstract][Full Text] [Related]
5. CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy.
Liu JQ; Hu A; Zhu J; Yu J; Talebian F; Bai XF
Adv Exp Med Biol; 2020; 1223():155-165. PubMed ID: 32030689
[TBL] [Abstract][Full Text] [Related]
6. Regulation of myeloid cell function through the CD200 receptor.
Jenmalm MC; Cherwinski H; Bowman EP; Phillips JH; Sedgwick JD
J Immunol; 2006 Jan; 176(1):191-9. PubMed ID: 16365410
[TBL] [Abstract][Full Text] [Related]
7. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms of CD200-CD200R induce diverse outcomes in cancer treatment.
Liao KL; Watt KD; Protin T
Math Biosci; 2023 Nov; 365():109072. PubMed ID: 37734537
[TBL] [Abstract][Full Text] [Related]
9. The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K.
Khan IZ; Del Guzzo CA; Shao A; Cho J; Du R; Cohen AO; Owens DM
Cancer Res; 2021 Oct; 81(19):5021-5032. PubMed ID: 34183355
[TBL] [Abstract][Full Text] [Related]
10. Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions.
Talebian F; Liu JQ; Liu Z; Khattabi M; He Y; Ganju R; Bai XF
PLoS One; 2012; 7(2):e31442. PubMed ID: 22319630
[TBL] [Abstract][Full Text] [Related]
11. CD200 receptor controls sex-specific TLR7 responses to viral infection.
Karnam G; Rygiel TP; Raaben M; Grinwis GC; Coenjaerts FE; Ressing ME; Rottier PJ; de Haan CA; Meyaard L
PLoS Pathog; 2012; 8(5):e1002710. PubMed ID: 22615569
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.
Erin N; Podnos A; Tanriover G; Duymuş Ö; Cote E; Khatri I; Gorczynski RM
Oncogene; 2015 Jul; 34(29):3860-70. PubMed ID: 25263452
[TBL] [Abstract][Full Text] [Related]
13. Ligation of CD200R by CD200 is not required for normal murine myelopoiesis.
Rijkers ES; de Ruiter T; Buitenhuis M; Veninga H; Hoek RM; Meyaard L
Eur J Haematol; 2007 Nov; 79(5):410-6. PubMed ID: 17803680
[TBL] [Abstract][Full Text] [Related]
14. The immune inhibitory complex CD200/CD200R is developmentally regulated in the mouse brain.
Shrivastava K; Gonzalez P; Acarin L
J Comp Neurol; 2012 Aug; 520(12):2657-75. PubMed ID: 22323214
[TBL] [Abstract][Full Text] [Related]
15. Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?
Minas K; Liversidge J
Crit Rev Immunol; 2006; 26(3):213-30. PubMed ID: 16928187
[TBL] [Abstract][Full Text] [Related]
16. The expressions of CD200 and CD200R molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy.
Darmochwal-Kolarz DA; Kludka-Sternik M; Chmielewski T; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
Am J Reprod Immunol; 2012 Jun; 67(6):474-81. PubMed ID: 22462561
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis.
Copland DA; Calder CJ; Raveney BJ; Nicholson LB; Phillips J; Cherwinski H; Jenmalm M; Sedgwick JD; Dick AD
Am J Pathol; 2007 Aug; 171(2):580-8. PubMed ID: 17600119
[TBL] [Abstract][Full Text] [Related]
18. CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment.
Xin C; Zhu J; Gu S; Yin M; Ma J; Pan C; Tang J; Zhang P; Liu Y; Bai XF; Mo X; Xu M; Zhu H
Cancer Immunol Immunother; 2020 Nov; 69(11):2333-2343. PubMed ID: 32514618
[TBL] [Abstract][Full Text] [Related]
19. CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts.
Cui W; Cuartas E; Ke J; Zhang Q; Einarsson HB; Sedgwick JD; Li J; Vignery A
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14436-41. PubMed ID: 17726108
[TBL] [Abstract][Full Text] [Related]
20. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue.
Stack G; Jones E; Marsden M; Stacey MA; Snelgrove RJ; Lacaze P; Jacques LC; Cuff SM; Stanton RJ; Gallimore AM; Hussell T; Wilkinson GW; Ghazal P; Taylor PR; Humphreys IR
PLoS Pathog; 2015 Feb; 11(2):e1004641. PubMed ID: 25654642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
